FY2024 EPS Estimates for OTC:GTBIF Cut by Analyst

Green Thumb Industries Inc. (OTC:GTBIF - Free Report) - Alliance Global Partners reduced their FY2024 EPS estimates for shares of Green Thumb Industries in a research note issued on Wednesday, October 30th. Alliance Global Partners analyst A. Grey now expects that the company will earn $0.33 per share for the year, down from their prior estimate of $0.34. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.35 per share. Alliance Global Partners also issued estimates for Green Thumb Industries' FY2025 earnings at $0.22 EPS.

Several other equities analysts have also recently weighed in on GTBIF. Craig Hallum upgraded shares of Green Thumb Industries to a "strong-buy" rating in a research report on Monday, September 16th. Ventum Cap Mkts raised Green Thumb Industries to a "strong-buy" rating in a research report on Tuesday, August 6th.

Green Thumb Industries Stock Performance

Shares of OTC:GTBIF traded up $0.39 during midday trading on Monday, reaching $10.68. The company had a trading volume of 228,767 shares, compared to its average volume of 441,841. The company has a fifty day simple moving average of $10.30. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 36.75 and a beta of 1.40. Green Thumb Industries has a 1-year low of $8.78 and a 1-year high of $16.33.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.